A super-enhancer-regulated RNA-binding protein cascade drives pancreatic cancer

Direct RNA sequencing provides unique insights into RNA biology. Learn more about how this technology is being applied to advance discovery and ensure rigorous quality control for RNA medicines.

The 5th Annual mRNA Therapeutics Summit brought together leaders from biotech, pharma, and academia to discuss the breakthroughs shaping RNA medicines and the bottlenecks that remain. Our recap highlights key takeaways, emerging opportunities, and the trends likely to define the next decade of RNA therapeutic development.

Micropeptides, proteins under 100 amino acids, are emerging regulators of cancer, metabolism, and neurodegeneration. Learn how ribosome profiling can reveal these hidden proteins, driving the discovery of new biomarkers and development of novel therapeutics.

RNA is unlocking the ability to develop life‑saving therapies at unprecedented speed. The recent success with baby KJ demonstrates how RNA medicine can move a personalized treatment from diagnosis to clinic in less than a year.